82 / 89
82
newly diagnosed multiple myeloma patients included in
the
PETHEMA/GEM2000
study.
Haematologica
2010;95:1913-20.
40.
Kumar A, Kharfan-Dabaja MA, Glasmacher A,
Djulbegovic B. Tandem versus single autologous
hematopoietic cell transplantation for the treatment of
multiple myeloma: a systematic review and meta-
analysis. J Natl Cancer Inst 2009;101:100-6.
41.
Lahuerta JJ, Grande C, Martínez-Lopez J, De La Serna J,
Toscano R, Ortiz MC, et al. Tandem transplants with
different high-dose regimens improve the complete
remission rates in multiple myeloma. Results of a Grupo
Español de Síndromes Linfoproliferativos/Trasplante
Autólogo de Médula Osea phase II trial. Br J Haematol
2003;120:296-303.
42.
Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C,
Fuzibet JG, et al. Single versus double autologous stem-
cell transplantation for multiple myeloma. N Engl J Med
2003;349:2495-502.
43.
Cavo M, Tosi P, Zamagni E, Cellini C, Tacchetti P,
Patriarca F, et al. Prospective, randomized study of single
compared
with
double
autologous
stem-cell
transplantation for multiple myeloma: Bologna 96 clinical
study. J Clin Oncol 2007;25:2434-41.
44.
Abdelkefi A, Ladeb S, Torjman L, Ben Othman T, Lakhal
A, Ben Romdhane N, et al. Single autologous stem-cell
transplantation followed by maintenance therapy with
thalidomide is superior to double autologous
transplantation in multiple myeloma: results of a
multicenter
randomized
clinical
trial.
Blood.
2009;113:6265. Retraction of:
Abdelkefi A, Ladeb S, Torjman L, Othman TB, Lakhal A, Romdhane NB, Omri HE, Elloumi M, Belaaj H, Jeddi R, Aissaouï L, Ksouri H, Hassen AB, Msadek F, Saad A, Hsaïri M, Boukef K,